Emerging data highlights the potential of metabolic hormones and dual-agonist methods to revolutionize our view of cellular response. These miniature peptides, often functioning as potent regulatory mimics, offer a unique opportunity to simultaneously adjust multiple pathways, surpassing the drawbacks of traditional individual therapeutic molecules